Authorisation by a pharmacist who is absent or treated as absent – handing out checked and bagged prescriptions

Pharmacy Guides iconPharmacy guide

This guide will help you with pharmacy supervision legislation (coming into force on 7 January) enabling pharmacists to authorise a member of the pharmacy team to hand out prescriptions in their absence that have been checked and are ready to go to the patient without any further intervention from the pharmacist – so called ‘checked and bagged prescriptions’. 

It can help you identify the medicines or scenarios that may require pharmacist intervention or escalation before being handed out, establish appropriate safeguards to manage any risks, and update SOPs to support patient safety.

Published: 10 December 2025

What’s changed

A pharmacist can authorise any competent member of the pharmacy team to make the final sale or supply of a ‘checked and bagged medicine’ (i.e., a prescription only (POM) or pharmacy (P) medicine that has been checked for clinical appropriateness and accuracy and dispensed by or under the supervision of a pharmacist and is ready for sale or supply) to patients or patient representatives in the pharmacist’s absence (e.g., if they are temporarily absent from the premises because they are on their lunch or rest break) – or where the pharmacist is treated as being absent (e.g., if they are unavailable or not in a position to intervene because they are providing clinical services to someone in the consultation room and cannot be interrupted).

SEE OUR POSITION STATEMENT FOR FURTHER INFORMATION

Please note, this change does not affect current responsible pharmacist (RP) rules (member login required to access).

Key messages

It’s important to remember:

  • Authorisation is optional – pharmacists are not under any legal obligation to operate authorisations and may use their professional judgement (registered user login required to access) to choose whether to authorise others
  • Nothing in the order prevents intervention by another pharmacist if needed or if risks arise. Another pharmacist can intervene or stop a transaction or supply of a medicine, regardless of authorisation. If they, in their clinical judgement, decide that a medicine is not safe or appropriate, a transaction or supply should not go ahead and should be discussed with the authorising pharmacist and prescriber as appropriate
  • RP, superintendent (SP) and authorising pharmacist roles are distinct, and they remain professionally accountable for their individual roles
  • Prioritise patient safety – consider the risks and how to safeguard them
  • Standard operating procedures (SOPs) should outline authorisation, pharmacist intervention and escalation and cover roles and responsibilities, training, audit and risk assessments.

Checklist of considerations 

Here are some considerations around authorising others to make the final supply of checked and bagged medicines.

  1. Risk assessments – identify and manage potential risks (with appropriate safeguards in place) associated with authorising others to make the final supply of checked and bagged medicines. Review at regular intervals and, if necessary, revise or update risk assessments. 
  2. SOPs – SOPs should be accessible to the pharmacy team and regularly reviewed, maintained and signed where needed. Review current SOPs around handing out medicines and, if necessary, revise or update them. 
  3. Authorisation – the pharmacist is responsible for deciding if authorisation is appropriate, who to authorise (depending on risk assessment, professional judgment and skill mix) and whether to withdraw/amend authorisation if at any time risks arise. Review and outline expectations around authorisation in the SOPs. 
  4. Pharmacist escalation or intervention – certain higher-risk medicines and scenarios may require pharmacist intervention or escalation before being handed out. Review and outline these in the SOPs with appropriate safeguards to manage them 
  5. Training – any member pharmacy team authorised to hand out checked and bagged medicines must have the appropriate training, competence, confidence and confirm they have the appropriate skills and qualifications to carry out such tasks and work within their scope of practice. Training should be covered in the SOPs, including demonstrating competence to perform specific tasks and regular reviews of individuals authorised to hand out checked and bagged medicines
  6. Audit – regularly monitor, evaluate and improve the process and share learning in practice.
  7. Communicate necessary information with pharmacy teams, patients and their representatives – including conditions/limitations for authorisation, changes in authorisations and how a pharmacist can be contacted during periods of absence to intervene and provide support if necessary and within a reasonable timeframe 
  8. Roles and responsibilities – everyone in the pharmacy team needs to know their roles and responsibilities.

SOPs

It’s important to review and update your SOPs for handing out medicines and consider the following around authorising others to make the final supply of checked and bagged medicines: See the roles and responsibilities on who should develop SOPs. 

  • How authorisation can be given and recorded – authorisation can be:
    • Given in writing or orally – record keeping concerning an authorisation should be defined in the SOPs
    • Given subject to conditions or restrictions
    • Varied or withdrawn by the pharmacist.
  • Who can give authorisation to hand out checked and bagged medicines when a pharmacist is absent or treated as being absent
    • Only a pharmacist (it does not have to be the RP but it must be a pharmacist) can:
      • Authorise any member of the pharmacy team to hand out checked and bagged medicines in their absence
      • Decide if authorisation is appropriate and who can receive authorisation – this is optional and must be based on professional judgement, risk assessment and skill mix on the day
      • Withdraw or amend authorisation at any time if risks arise.
  • Who can receive authorisation to hand out checked and bagged medicines when a pharmacist is absent or treated as being absent 
    • Authorisation can be given to a pharmacy technician or other suitably skilled or experienced member of the pharmacy team
    • Any pharmacy team members authorised to hand out checked and bagged medicines must have the appropriate training, competence, confidence and confirm they have the appropriate skills and qualifications to carry out such tasks and work within their scope of practice. 
  • Withdrawing/amending authorisation – which could also cover any variation/change/removal to the authorisation, and scenarios when any other pharmacist can intervene or override 
    • Only the pharmacist who has given the authorisation can override, withdraw or amend the authorisation already given if, in their professional judgement, the change is necessary – consider who made the original authorisation and how long it was meant to remain in place
    • The pharmacist is responsible for communicating any changes to the authorisation effectively and in a timely way to members of the pharmacy team operating under the authorisation. Ensure they fully understand the change at the time it is made
    • Nothing in the order prevents intervention by another pharmacist if needed or risks arise. Another pharmacist can intervene or stop a transaction or supply of a medicine, regardless of authorisation. If they, in their clinical judgement, deem that a medicine is not safe or appropriate, a transaction or supply should not go ahead and should be discussed with the authorising pharmacist and prescriber as appropriate.
  • Scope and duration of authorisation (how long they should stay in place) 
  • Conditions and restrictions for authorisation 
  • How to raise concerns if an authorisation is not professionally appropriate (by the pharmacy team member given authorisation or by the authorising pharmacist)
  • Which types of prescription medicines may require intervention by the pharmacist before handing out to a patient or their representative – see the section on medicines that may require pharmacist escalation or intervention
  • Which scenarios may require a pharmacist intervention or escalation before handing out to a patient or their representative – see the section on scenarios that may require pharmacist escalation or intervention
  • Arrangements that apply during the absence of the authorising pharmacist including how to contact the pharmacist in an emergency, where intervention is required or where a patient wants to engage with the pharmacist, using technology or in person, within a reasonable timescale
  • Roles and responsibilities – see the section on roles and responsibilities.

Medicines that may require pharmacist escalation or intervention 

Certain types of prescription medicines may require pharmacist intervention or escalation before being handed out. The SOP should clearly define these prescription medicines and outline appropriate safeguards to manage them – e.g., using visual indicators such as stickers to highlight items requiring additional attention. 

Examples of higher-risk prescription medicines may include:

  • Newly prescribed medicines 
  • Changes to medicine dose/strength/formulation where counselling may be required 
  • Antibiotics for serious acute infections
  • Emergency contraception
  • Medicines supplied under a serious shortage protocol (SSP)
  • Controlled drugs (CDs) – e.g., supervised consumption of methadone/buprenorphine and CDs with record-keeping requirements and CD balances 
  • Fridge items – e.g., insulin 
  • High-risk medicines with:
    • Narrow therapeutic index, e.g., lithium 
    • Serious adverse effects
    • Interactions
    • Withdrawal effects
    • Time critical 
    • Complex or unusual dosing
    • Monitoring or recording requirements, e.g., steroids and methotrexate.
  • Medicines for vulnerable patients where specific advice regarding dosing may be needed, e.g., children, older people, or people with learning disabilities.  

This list is not exhaustive, and additional medicines may be included as appropriate. 

Scenarios that may require pharmacist escalation or intervention 

Certain scenarios may require pharmacist intervention or escalation before being handed out. The SOP should clearly define these scenarios and outline appropriate safeguards to manage them – e.g., asking the patient/representative to return to the pharmacy once the pharmacist is available or taking a telephone number so the pharmacist can call them at a convenient time. 

Examples of scenarios may include:

  • Higher-risk medicines that may not be suitable for pharmacy team members to hand out in the absence of the pharmacist without appropriate intervention
  • Where the pharmacy team identify that the involvement of a pharmacist is needed, e.g., if a patient or their representative has information that requires pharmacist intervention, if a patient has questions they can’t answer or complains of side effects/symptoms
  • When the patient or their representative asks to speak to the pharmacist  
  • When a pharmacist has indicated a need to speak to a patient. 

This list is not exhaustive, and additional scenarios and safeguards may be included as appropriate. 

Roles and responsibilities 

Everyone in the pharmacy team needs to know the roles and responsibilities of others and themselves around authorisation. 

Pharmacy teams should be prepared to explain to patients and their representatives the reasoning for different hand-out processes on different days.

It’s important to remember that the roles of the authorising pharmacist, RP and SP are legally distinct. A pharmacist who authorises is authorising as a pharmacist regardless of whether they are also working as an RP.

SP and pharmacy owner 

  • Conduct risk assessments and audits (member login required to access) or appoint someone in the team to do so, e.g., RP/pharmacist/pharmacy technician
  • Develop clear SOPs for authorisation and escalation, or appoint someone in the team to do so, e.g., RP/pharmacist/pharmacy technician 
  • Provide training and refreshers to pharmacy team members (including locums) to ensure they are suitable for the task 
  • Do not compromise the ability for pharmacists working in a community pharmacy to meet their professional obligations
  • Consider how the process will impact the day-to-day operations, people who use your pharmacy services and pharmacy team 
    • Does the pharmacy team have any concerns or feedback? 

Authorising pharmacists (including RP, locums and relief pharmacists)

  • Ensure you are confident working within a pharmacy that follows this process before accepting a role – whether employed or self-employed – by reviewing and signing the relevant SOPs
    • Any decision to deviate must be based on professional judgement, considering risks, patient safety and other relevant factors
    • In your professional judgement, if the SOP cannot be implemented safely or you have concerns, notify the SP or owner. This will allow them to review the concerns raised, make any necessary changes and share best practice 
  • Decide whether to authorise pharmacy team members and who to give authorisation to
  • Communicate clearly the conditions for authorisation to the pharmacy team and patients and stay contactable during periods of absence to intervene and provide support if necessary 
  • Withdraw or amend authorisation at any time if risks arise 
    • The authorising pharmacist should communicate to the team any authorisation that is given or withdrawn effectively and in a timely way to ensure they fully understand the change at the time it is made.
  • Remain professionally accountable for the safe and effective operation of the pharmacy during your responsibility as authorising pharmacist – only pharmacists can authorise and are accountable for authorisations
  • Another pharmacist can intervene or stop a transaction or supply of a medicine, regardless of authorisation. If they, in their clinical judgement, deem that a medicine is not safe or appropriate, a transaction or supply should not go ahead and should be discussed with the authorising pharmacist and prescriber as appropriate
  • Manage risks identified in the pharmacy and ensure they have been mitigated or minimised to maintain patient safety 
  • You may find our professional judgement and locum guides (member login required to access) helpful.

Pharmacy technicians and the wider pharmacy team

  • Read, sign and follow relevant internal SOPs 
  • Complete appropriate training with regular refreshers as required to ensure ongoing confidence and competence 
    • Only hand out check and bagged medicines if you feel competent and confident – refuse tasks if you are not
  • Know who the authorising pharmacist is on any given day and who is authorised to hand out checked and bagged medicines to a patient or their representative in the absence of a pharmacist – see internal SOPs
  • Know when to escalate to the pharmacist for intervention – see internal SOPs 
  • If you are a pharmacy technician responsible for writing the SOPs, see the section on SOPs

Glossary

Absence or absent – This guidance uses the definition of ‘absence of the pharmacist’ defined under Section 72A of the Medicines Act and the subordinate Medicines (Pharmacies) (Responsible Pharmacist) Regulations 2008. E.g., the pharmacist is temporarily absent from the premises because they are on their lunch or rest break.   

Authorisation – Authorisation in this case is about the handing out of checked and bagged medicines. The RPS defines authorisation as a formal, auditable process of delegation by a pharmacist to a registered pharmacy technician, or another competent member of the pharmacy team for specific, defined tasks.  

Checked and bagged medicines – A POM or P medicine that has been dispensed (which has been checked for clinical appropriateness and accuracy) and is ready for sale or supply at or from a registered pharmacy. This definition is derived from The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025.

Supervision – This guidance uses the pre-existing interpretations of pharmacy supervision best illustrated in the Government’s response to the pharmacy supervision consultation of July 2025 and RPSGB 2005 interim guidance. The RPS plans to revise the definition in 2026 if needed. 

Treated as being absent – This guidance uses the definition as ‘a pharmacist who is at the pharmacy but not available to intervene in, or not in a position to intervene in, the transaction in question’. E.g., the pharmacist is on the premises but cannot be interrupted as they are in a consultation room with a patient. This definition is derived from The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025.